What are UroGen Pharma's profit margins?

UroGen Pharma (URGN) runs a 89.7% gross margin and a -329.7% operating margin, with a -94.8% net margin.

Where do UroGen Pharma's ratios come from?

Every ratio is computed from UroGen Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

UroGen Pharma URGN Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Net margin	-94.8%+55.9pp	-139.8%+0.5pp	-170.6%-41.5pp	-164.4%-30.8pp	-150.7%-26.9pp
Free cash flow margin	-118.2%-1.3pp	-148.2%-40.9pp	-143.1%-35.3pp	-131.1%-29.9pp	-116.9%-19.1pp
Returns
Return on assets	-53.2%+8.6pp	-63.1%-8.5pp	-67.6%-21.1pp	-63.2%-3.0pp	-61.8%+4.8pp
Efficiency
Asset turnover	0.6×+0.2×	0.5×+0.1×	0.4×0.0×	0.4×-0.1×	0.4×-0.1×
Liquidity
Current ratio	4.7×-1.0×	4×-2.0×	4×-5.0×	4.1×-4.0×	5.6×-1.8×
Quick ratio	4.3×-1.2×	3.7×-2.2×	3.8×-5.0×	4×-3.9×	5.5×-1.7×
Cash ratio	2.2×-0.3×	2.4×-1.4×	2.1×-1.7×	2×-4.5×	2.5×-2.5×
Leverage
Debt-to-assets	0.8×+0.3×	0.6×+0.2×	0.7×+0.3×	0.6×+0.3×	0.5×0.0×
Valuation
Market capitalization	$875.31M+71.7%	$1.1B+144%	$922.97M+76.5%	$635.82M+4.9%	$509.8M-5.9%
Enterprise value	$962.43M+80.9%	$1.12B+177%	$962.87M+84.9%	$670.39M+38.1%	$532.13M+4.4%
Price / sales	6.2×+0.7×	10×+5.0×	9.6×+3.7×	6.7×-0.4×	5.5×-0.9×
EV / sales	6.9×+1.1×	10.2×+5.7×	10×+4.1×	7.1×+1.4×	5.8×-0.3×
Free cash flow yield	-19%+2.1pp	-14.8%+6.8pp	-15%+3.5pp	-19.4%-5.2pp	-21.1%-5.8pp
Earnings yield	-15.2%+11.9pp	-14%+14.2pp	-17.8%+4.2pp	-24.4%-5.6pp	-27.2%-7.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are UroGen Pharma's profit margins?: UroGen Pharma (URGN) runs a 89.7% gross margin and a -329.7% operating margin, with a -94.8% net margin.
Where do UroGen Pharma's ratios come from?: Every ratio is computed from UroGen Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.